News
Sònia Forcales: “BAF60c plays an essential role for myogenic differentiation”
The conference “BAF60c-MyoD complex poises chromatin for myogenic differentiation” by Dr. Sònia Forcales, from the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), which took place on November 22th in the Auditorium of the University of Barcelona (Campus Bellvitge) focused on the role of BAF60c in muscle and muscular dystrophy differentiation. Dr. Forcades talked […]
Fernando Fernandez Aranda: ”eating disorders are not nutritional problems, but mental problems”
Eating behaviour disorders are not mental but nutritional problems. Although it has been repeated many times in television series, reports and journal articles, it seems that not everyone is quite clear about this fact, judging from the face of disbelief of some of those attending the talk by Fernando Fernández Aranda at Centre Cultural Sant […]
Stopping cancerous cells flow promotes metastasis
Nine out of ten cancer deaths occur because of metastasis. This phenomenon happens when cancer cells break away from the original tumour and spread through the body anchoring to other organs and form new tumours. IDIBELL researchers have participated in an investigation showing that Prrx1 protein prevents cancer cells lodge in other organs and, therefore, […]
IDIBELL licenses to Janus a patent for the treatment of immune diseases
The Bellvitge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the company Janus Developments of a patent for an immunomodulatory product for treating immune diseases such as autoimmune diseases, sepsis, hypersensitivity disorders (including, allergic reactions) or post-transplant rejection. The patent has been developed by the researcher of the Human Molecular Genetics group Josep […]
The best experts in the world in personalized cancer medicine meet in L’Hospitalet
On 3 and 4 December the Convention Center of Hesperia L’Hospitalet will hold the IDIBELL Cancer Conference on Personalized Cancer Medicine. The conference will bring together a hundred of researchers around the world. The purpose of the meeting is to highlight recent advances in the biology and natural history of cancer provides new targets for […]
Manel Esteller, ”if the alphabet is genetics, spelling is epigenetics”
Why don’t identical twins have the same disease at the same time? Why do two cats who share the same DNA have different spots? Why do teenagers have mood changes? The answer is in epigenetics, the discipline that deals with the genetic regulatory mechanisms that do not involve changes in the DNA sequence. The director […]
Enrique de Álava: “We are trying to use a combine therapy for Ewing sarcoma”
The conference “Search, validation and clinical translation of new therapeutic targets in Ewing sarcoma found by integrative genomic analyses” by Enrique de Álava, researcher at the Cancer Research Centre (CIC), at the Hospital University of Salamanca and the Spanish High Research Council (CSIC), takes place last 9th November in IDIBELL. “To try to translate into […]
IDIBELL wins the Antonio Baró prize for its commitment to the prevention of occupational hazards
IDIBELL has been awarded with the 2012 Antonio Baró prize for prevention of occupational hazards. The award is given by MC Mutual to companies of Spain. The award recognizes the work of companies making effective policies for the prevention of occupational hazards and demonstrating a commitment to continuous improvement of the working conditions of its […]
Manel Esteller participates in a Royal Society meeting
The Royal Society will host the first scientific meeting between Spain and the United Kingdom, with the title “Networking Nations: Scientific opportunities in the UK and Spain”, on 28 November. This meeting will contribute to the implementation of the Society’s strategic objective to foster international cooperation by strengthening its links with European academies, funders, and […]